-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point
Paolo Spagnolo,Fabrizio Luppi
Review Article: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation